Company intelligence / Profile preview

Nfocus Neuromedical

Palo Alto, California, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

Nfocus Neuromedical developed next-generation endovascular devices for treating brain aneurysms and hemorrhagic stroke. Its flagship Luna™ Aneurysm Embolization System demonstrated positive one-year follow-up results in a European clinical study, showing stability and rapid deployment for a variety of aneurysm types. The Luna AES received CE Mark approval, with plans for commercial launch in Europe around 2013[5]. The company also received FDA clearance for its guiding catheter technology[10].

Therapeutic areas: Neurology
Modalities: DeviceImplantable deviceCatheter-based therapy
Industry: Implantable Medical Devices

Partnerships

Technology Partners (investor)Oxford Bioscience Partners (investor)DFJ ePlanet Ventures / ePlanet Capital

Beyond the preview

Go deeper on Nfocus Neuromedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nfocus Neuromedical.

Explore the full profile